Duration of Use of Highly Effective Reversible Contraception

N/ACompletedNCT02414919

Bayer13,880 enrolled

Overview

To assess the proportion of women who use HERC for ≥2 years of duration

Study Type

OBSERVATIONAL

Enrollment

13,880

Conditions

Pregnancy

Interventions

Mirena (Levonorgestrel IUS, BAY86-5028)DRUG

Levonorgestrel-releasing intrauterine device 20 mcg/day

ParaGardDRUG

Copper T380A

Implanon/NexplanonDRUG

Etonorgestrel contraceptive implant

Eligibility

Sex: FEMALEMin age: 15 YearsMax age: 44 Years

Medical Language ↔ Plain English

Inclusion Criteria: -Women who had an IUD or contraceptive implant inserted and removed within the University of Utah from January 1, 2004 to October 31, 2012

Locations (1)

Unnamed facility

Salt Lake City, Utah, United States

Outcomes

Primary Outcomes

Proportion of women who use HERC

Time frame: 2 years post-HERC initiation

Secondary Outcomes

Duration of real world use of three different HERC devices

Time frame: 2 years post-HERC initiation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.